Connecticut Zantac Cancer Lawsuit Attorney

What You Need to Know About Ongoing Ranitidine Litigation

In April 2020, the Food and Drug Administration (FDA) issued a recall of all ranitidine medications and requested manufacturers to withdraw these products from shelves. Ranitidine is a common ingredient in antiacids, but a recent investigation revealed that it contains a probable carcinogen called N-Nitrosodimethylamine (NDMA). According to the FDA’s recall, the level of NDMA in ranitidine-containing products, such as Zantac, can increase over time and/or when products are stored at temperatures above room level. As a result, countless consumers were likely put at risk of consuming dangerous levels of NDMA, which can lead to numerous forms of cancer.

If you or a loved one took Zantac or a similar ranitidine medication over a prolonged period of time and later developed cancer, you could be entitled to take part in ongoing litigation. Our Connecticut Zantac cancer lawsuit attorneys at RisCassi & Davis, P.C. are currently taking cases involving patients who took ranitidine medication, leading to cancer. We encourage you to reach out to us today for a free initial consultation with a member of our team.

Call RisCassi & Davis, P.C. at (860) 245-2412 or contact us online to request a free, no-obligation consultation. We do not charge attorneys’ fees unless we win your case. 

What Is Ranitidine & How Is It Dangerous?

Ranitidine is a type of drug known as a histamine-2 (H-2) blocker. It helps reduce the amount of acid produces by the stomach and, therefore, serves as an effective medication to help treat and prevent heartburn, gastroesophageal reflux disease (GERD), and stomach/intestinal ulcers.

While ranitidine itself is not necessarily dangerous, many ranitidine medications contain an impurity called N-Nitrosodimethylamine, or NDMA. NDMA is a naturally occurring substance that can also be produced as a result of various industrial processes. Because ranitidine contains both nitrite and dimethylamine, the two elements that form NDMA, it has a high risk of naturally creating NDMA over time or when stored at high temperatures. Additionally, recent studies have shown that conditions in the human digestive system can also lead to the formation of NDMA in ranitidine once ingested.

This can have numerous negative health consequences for individuals who take Zantac and other ranitidine products; namely, they can develop cancer.

What Types of Cancer Does Zantac Cause?

NDMA has been used in labs to create cancer in rats. It is indisputably a carcinogen, meaning it can potentially cause cancer in humans, as well.

Zantac and other ranitidine medications have been linked to several forms of cancer, including but not limited to:

• Colorectal cancer
• Stomach cancer
• Intestinal cancer
• Esophageal cancer
• Liver cancer
• Bladder cancer
• Breast cancer
• Pancreatic cancer
• Prostate cancer
• Throat cancer
• Nasal cancer
• Thyroid cancer
• Ovarian cancer

If you were diagnosed with cancer of if someone you love died from cancer after taking Zantac, you could be entitled to bring a defective drug claim and recover compensation for your damages under Connecticut’s product liability laws.